Open in Screener

BZUN

Baozun Inc ADR

Feb 26 • 04:00PM ET

2.58

-0.04 -1.53 %

Consumer Cyclical • Internet Retail • China • NASD

Peers: AMZN BABA JD PDD SHOP EBAY MELI ETSY CHWY GRPN

| Held by: DFEM DFAE EWX PGJ APIE DFAX DFSE DFEV AVDS

Index	-	P/E	-	EPS (ttm)	-0.49	Insider Own	0.17%	Shs Outstand	53.67M	Perf Week	-5.15%
Market Cap	138.47M	Forward P/E	8.22	EPS next Y	0.31	Insider Trans	0.00%	Shs Float	53.58M	Perf Month	-8.83%
Enterprise Value	357.99M	PEG	-	EPS next Q	-	Inst Own	19.78%	Short Float	0.92%	Perf Quarter	-11.64%
Income	-28.31M	P/S	0.10	EPS this Y	123.57%	Inst Trans	1.72%	Short Ratio	2.15	Perf Half Y	-14.29%
Sales	1.35B	P/B	0.29	EPS next Y	194.93%	ROA	-2.02%	Short Interest	0.50M	Perf YTD	-3.01%
Book/sh	8.98	P/C	0.37	EPS next 5Y	-	ROE	-5.26%	52W High	4.88 -47.13%	Perf Year	-25.00%
Cash/sh	6.98	P/FCF	-	EPS past 3/5Y	3.12% -	ROIC	-4.71%	52W Low	2.12 21.70%	Perf 3Y	-57.28%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-3.50% 4.45%	Gross Margin	73.76%	Volatility	5.57% 4.79%	Perf 5Y	-94.38%
Dividend TTM	-	EV/Sales	0.26	EPS Y/Y TTM	9.43%	Oper. Margin	-1.07%	ATR (14)	0.13	Perf 10Y	-57.14%
Dividend Ex-Date	-	Quick Ratio	1.50	Sales Y/Y TTM	6.05%	Profit Margin	-2.09%	RSI (14)	40.59	Recom	1.60
Dividend Gr. 3/5Y	- -	Current Ratio	1.87	EPS Q/Q	-25.15%	SMA20	-3.30%	Beta	0.35	Target Price	4.03
Payout	-	Debt/Eq	0.65	Sales Q/Q	4.97%	SMA50	-6.03%	Rel Volume	1.45	Prev Close	2.62
Employees	7650	LT Debt/Eq	0.16	Earnings	Nov 25 BMO	SMA200	-15.84%	Avg Volume	229.75K	Price	2.58
IPO	May 21, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	- 1.52%	Trades		Volume	332,807	Change	-1.53%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-30-24	Downgrade	CLSA	Outperform → Hold
Mar-26-24	Downgrade	China Renaissance	Buy → Hold
Feb-08-24	Upgrade	Daiwa Securities	Outperform → Buy
Feb-27-23	Upgrade	CLSA	Underperform → Outperform	$4.40 → $7
Jan-30-23	Initiated	JP Morgan	Overweight
Jan-11-23	Upgrade	JP Morgan	Neutral → Overweight	$9 → $10
May-16-22	Upgrade	JP Morgan	Underweight → Neutral	$5 → $8
Mar-14-22	Downgrade	JP Morgan	Overweight → Underweight	$5
Mar-11-22	Upgrade	Credit Suisse	Underperform → Neutral	$8.30
Dec-02-21	Downgrade	CLSA	Buy → Outperform
Aug-20-21	Downgrade	Daiwa Securities	Buy → Neutral	$42 → $20
Jul-23-21	Downgrade	Credit Suisse	Outperform → Underperform
Jun-08-21	Resumed	JP Morgan	Overweight	$45
May-19-21	Upgrade	Credit Suisse	Neutral → Outperform	$41
Jan-25-21	Upgrade	CLSA	Outperform → Buy	$42
Nov-24-20	Downgrade	Credit Suisse	Outperform → Neutral
Jun-03-20	Upgrade	Credit Suisse	Neutral → Outperform	$36
Mar-31-20	Downgrade	BofA/Merrill	Buy → Neutral
Nov-22-19	Downgrade	Credit Suisse	Outperform → Neutral
Aug-22-19	Downgrade	CLSA	Buy → Outperform

Show Previous Ratings

Nov-25-25 02:00PM	Baozun Inc (BZUN) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Focus on ... (GuruFocus.com) -5.82%
05:00AM	Baozun Announces Third Quarter 2025 Unaudited Financial Results (PR Newswire)
Nov-11-25 05:00AM	Baozun to Announce Third Quarter 2025 Unaudited Financial Results on November 25, 2025 (PR Newswire)
Sep-22-25 01:32PM	Accenture Pre-Q4 Earnings: Is the Stock a Portfolio Must-Have? (Zacks)
Aug-29-25 03:04AM	Baozun Inc (BZUN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansion (GuruFocus.com) +6.27%
06:00AM	Loading…
Aug-28-25 06:00AM	Baozun Announces Second Quarter 2025 Unaudited Financial Results (PR Newswire) +12.72%
Aug-14-25 06:00AM	Baozun to Announce Second Quarter 2025 Unaudited Financial Results on August 28, 2025 (PR Newswire)
Jul-21-25 09:40AM	Is Baozun (BZUN) Stock Outpacing Its Computer and Technology Peers This Year? (Zacks)
Jun-18-25 06:00AM	Baozun Announces Results of Annual General Meeting of Shareholders (PR Newswire)
May-22-25 03:03AM	Baozun Inc (BZUN) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansions ... (GuruFocus.com)
May-21-25 06:00AM	Baozun Announces First Quarter 2025 Unaudited Financial Results (PR Newswire)
May-16-25 06:00AM	Baozun Schedules Annual General Meeting of Shareholders (PR Newswire)
May-07-25 06:00AM	Baozun to Announce First Quarter 2025 Unaudited Financial Results on May 21, 2025 (PR Newswire) +6.84%
Apr-23-25 07:17AM	Baozun Releases 2024 Sustainability Report (PR Newswire)
06:38AM	Baozun Files Annual Reports for Fiscal Year 2024 (PR Newswire)
06:00AM	Loading…
06:00AM	Baozun Releases 2024 Chairman Letter (PR Newswire)
Apr-18-25 11:35AM	Is Baozun Inc. (BZUN) the Best Internet Retail Stock to Buy According to Analysts? (Insider Monkey)
Mar-30-25 08:00AM	Baozun: Decent Buy Opportunity After The Correction (Seeking Alpha)
Mar-21-25 03:01AM	Baozun Inc (BZUN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansions (GuruFocus.com)
Mar-20-25 12:30PM	Baozun (BZUN) Q4 2024 Earnings Call Transcript (Motley Fool) -12.71%
09:01AM	Baozun Inc. (BZUN) Q4 2024 Earnings Call Transcript (SeekingAlpha)
06:00AM	Baozun Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results (PR Newswire)
Mar-19-25 06:00PM	Here's the major earnings before the open tomorrow (SeekingAlpha)
Mar-06-25 05:00AM	Baozun to Announce Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on March 20, 2025 (PR Newswire)
Feb-27-25 10:32AM	Why Baozun Inc. (BZUN) Is Skyrocketing So Far In 2025 (Insider Monkey) -5.52%
Feb-10-25 07:56PM	Why Baozun Inc. (BZUN) Is Skyrocketing (Insider Monkey)
Nov-22-24 02:02AM	Baozun Inc (BZUN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Profitability ... (GuruFocus.com)
Nov-21-24 11:00AM	Baozun (BZUN) Q3 2024 Earnings Call Transcript (Motley Fool) -8.11%
05:00AM	Baozun Announces Third Quarter 2024 Unaudited Financial Results (PR Newswire)
Nov-07-24 05:00AM	Baozun to Announce Third Quarter Financial Results of 2024 Unaudited Financial Results on November 21, 2024 (PR Newswire)
06:28AM	Loading…
Oct-17-24 06:28AM	Baozun Inc. Announces Strategic Share Repurchase (TipRanks)
Oct-16-24 06:50AM	Baozun Inc. Announces Strategic Share Repurchase (TipRanks)
Oct-10-24 06:29AM	Baozun Announces Share Repurchase Update (TipRanks)
Oct-09-24 07:27AM	Baozun Announces Recent Share Repurchase (TipRanks)
Oct-08-24 07:17AM	Baozun Announces Recent Share Repurchase (TipRanks) -10.22%
Oct-05-24 06:31AM	Baozun Announces Share Repurchase Update (TipRanks)
Aug-28-24 02:30PM	Baozun (BZUN) Q2 2024 Earnings Call Transcript (Motley Fool)
06:28AM	Baozun Announces Second Quarter 2024 Unaudited Financial Results (PR Newswire)
Aug-14-24 06:00AM	Baozun to Announce Second Quarter and Half-Year Interim Financial Results of 2024 Unaudited Financial Results on August 28, 2024 (PR Newswire)
Jun-12-24 07:26AM	Baozun Announces Results of Annual General Meeting of Shareholders (PR Newswire)
May-31-24 05:30AM	Alibaba sells stake in e-commerce branding services firm Baozun for US$21.8 million as part of corporate restructuring (South China Morning Post)
May-29-24 08:03AM	Baozun Inc. (NASDAQ:BZUN) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-28-24 01:00PM	Baozun (BZUN) Q1 2024 Earnings Call Transcript (Motley Fool)
10:52AM	BZUN Stock Earnings: Baozun Beats Revenue for Q1 2024 (InvestorPlace)
06:00AM	Baozun Announces First Quarter 2024 Unaudited Financial Results (PR Newswire)
May-14-24 06:00AM	Baozun to Announce First Quarter 2024 Unaudited Financial Results on May 28, 2024 (PR Newswire)
May-10-24 06:00AM	Baozun Schedules Annual General Meeting of Shareholders (PR Newswire)
Apr-19-24 07:13AM	Baozun Releases 2023 Sustainability Report (PR Newswire)
06:34AM	Baozun Strengthens Leadership Team (PR Newswire)
06:26AM	Baozun Files Annual Reports for Fiscal Year 2023 (PR Newswire)
06:00AM	Baozun Releases 2023 Chairman Letter (PR Newswire)
Mar-26-24 08:51AM	Baozun Inc. (NASDAQ:BZUN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-21-24 12:45PM	Baozun (BZUN) Q4 2023 Earnings Call Transcript (Motley Fool) -16.67%
10:53AM	BZUN Stock Earnings: Baozun Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace)
06:00AM	Baozun Announces Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results (PR Newswire)
Mar-07-24 04:32PM	7 Under-$10 Stocks That Will Be Worth $100 (or More!) by 2026 (InvestorPlace)
05:00AM	Baozun to Announce Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results on March 21, 2024 (PR Newswire)
Feb-16-24 03:15AM	20 Fastest Growing E-Commerce Companies in 2024 (Insider Monkey)
Jan-24-24 06:00AM	Baozun Announces US$20 million Share Repurchase Program (PR Newswire) +17.33%
Nov-24-23 08:44AM	Baozun Inc. (NASDAQ:BZUN) Q3 2023 Earnings Call Transcript (Insider Monkey) +5.46%
Nov-22-23 10:45AM	Baozun (BZUN) Q3 2023 Earnings Call Transcript (Motley Fool) -10.12%
05:00AM	Baozun Announces Third Quarter 2023 Unaudited Financial Results (PR Newswire)
Nov-08-23 05:00AM	Baozun to Announce Third Quarter Financial Results of 2023 Unaudited Financial Results on November 22, 2023 (PR Newswire)
Oct-05-23 05:17PM	Ray Dalio on Potential US-China War and Rise of China (Insider Monkey) +5.72%
Aug-29-23 08:12AM	Baozun Inc. (NASDAQ:BZUN) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-28-23 03:39PM	Why Baozun Stock Popped Today (Motley Fool) +12.47%
01:00PM	Baozun (BZUN) Q2 2023 Earnings Call Transcript (Motley Fool)
12:37PM	Hawaiian Electric Says Power Lines Not Responsible For Deadly Lahaina Fire, China Targets Stock Market Revival, FTC Pauses Legal Battle With Amgen's $28B Horizon Deal: Today's Top Stories (Benzinga)
06:00AM	Baozun Announces Second Quarter 2023 Unaudited Financial Results (PR Newswire)
Aug-14-23 06:00AM	Baozun to Announce Second Quarter and Half-Year Interim Financial Results of 2023 Unaudited Financial Results on August 28, 2023 (PR Newswire)
Jul-14-23 10:22AM	Positive week for Baozun Inc. (NASDAQ:BZUN) institutional investors who lost 52% over the past year (Simply Wall St.)
Jun-27-23 04:18PM	Why Alibaba, Bilibili, and Baozun Rose Today (Motley Fool)
Jun-15-23 08:20AM	Baozun Announces Results of Annual General Meeting of Shareholders (PR Newswire)
Jun-02-23 11:54AM	Why Shares of Alibaba, Dingdong, and Baozun Are Rising Today (Motley Fool)
May-25-23 02:47PM	Why Baozun Stock Was Falling Today (Motley Fool) -9.65%
01:30PM	Baozun (BZUN) Q1 2023 Earnings Call Transcript (Motley Fool)
06:00AM	Baozun Announces First Quarter 2023 Unaudited Financial Results (PR Newswire)
May-15-23 06:00AM	Baozun Schedules Annual General Meeting of Shareholders (GlobeNewswire) +7.57%
May-12-23 06:00AM	Baozun to Announce First Quarter 2023 Unaudited Financial Results on May 25, 2023 (GlobeNewswire) -5.42%
Apr-29-23 08:34AM	Baozun (NASDAQ:BZUN) investors are sitting on a loss of 90% if they invested five years ago (Simply Wall St.)
Apr-25-23 06:34AM	Baozun Releases 2022 Sustainability Report (GlobeNewswire)
06:27AM	Baozun Files Annual Report on Form 20-F for Fiscal Year 2022 (GlobeNewswire)
06:19AM	Baozun Releases 2022 Chairman Letter (GlobeNewswire)
Mar-25-23 08:41AM	Baozun Full Year 2022 Earnings: Misses Expectations (Simply Wall St.)
Mar-24-23 07:15AM	Baozun Inc. (NASDAQ:BZUN) Q4 2022 Earnings Call Transcript (Insider Monkey) -5.26%
06:42AM	Baozun (NASDAQ:BZUN) Might Be Having Difficulty Using Its Capital Effectively (Simply Wall St.)
Mar-22-23 12:18PM	Why Baozun Stock Was Sinking Today (Motley Fool) -9.41%
10:08AM	Baozun Registers 20% Topline Decline In Q4 Weighed Down By GMV Weakness; Updates On Newer Business Lines (Benzinga)
06:30AM	Baozun Announces Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results (GlobeNewswire)
Mar-08-23 06:00AM	Baozun to Announce Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results on March 22, 2023 (GlobeNewswire)
Mar-05-23 09:00AM	3 Stocks to Avoid This Week (Motley Fool)
Feb-10-23 02:55PM	JPMorgans Best Performing 15 Stock Picks for 2023 (Insider Monkey) -5.22%
Feb-01-23 12:20PM	Why Shares of Baozun, Hello Group, and HUYA Are Rising Today (Motley Fool) +7.88%
Jan-31-23 07:00PM	Baozun Completes Acquisition of Gap Shanghai and Announces Senior Management Appointment for Gap Greater China (GlobeNewswire)
Jan-20-23 05:14AM	Baozun Inc.'s (NASDAQ:BZUN) recent 13% pullback adds to one-year year losses, institutional owners may take drastic measures (Simply Wall St.) +6.08%
Dec-12-22 07:30AM	3 Stocks to Avoid This Week (Motley Fool) -13.45%
Dec-10-22 07:36AM	Is Baozun Inc. (NASDAQ:BZUN) Trading At A 50% Discount? (Simply Wall St.)
Dec-06-22 07:50AM	Baozun Inc. (NASDAQ:BZUN) Q3 2022 Earnings Call Transcript (Insider Monkey)
Dec-05-22 07:30AM	3 Stocks to Avoid This Week (Motley Fool) -5.91%
Nov-30-22 12:43PM	Why Baozun, Kanzhun, and GDS Holdings Rallied Today (Motley Fool) +7.96%

Baozun, Inc. is a holding company, which engages in the provision of brand electronic commerce (e-commerce) services and solutions. Its services include apparel and accessories, appliances, electronics, home and furnishings, food and health products, beauty and cosmetics, fast moving consumer goods, and mother and baby products, and insurance and automobiles. The firm operates through the E-Commerce and Brand Management segments. The company was founded by Wen Bin Qiu, Jun Hua Wu, and Qing Yu Zhang in August 2007 and is headquartered in Shanghai, China.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Yu Arthur	Executive	May 24 '25	Proposed Sale	3.23	289,673	935,644		May 23 06:27 AM

Open in Screener

LGIH

LGI Homes Inc

Feb 26 • 04:00PM ET

51.96

+1.07 2.10 %

Consumer Cyclical • Residential Construction • USA • NASD

Peers: DHI LEN PHM TOL KBH MTH TMHC NVR BZH HOV

| Held by: IJR VTI IWM VB XHB VBR FNDA VXF IJS ITB

Index	RUT	P/E	16.63	EPS (ttm)	3.12	Insider Own	12.85%	Shs Outstand	23.13M	Perf Week	-2.73%
Market Cap	1.20B	Forward P/E	15.55	EPS next Y	3.34	Insider Trans	0.00%	Shs Float	20.16M	Perf Month	3.63%
Enterprise Value	2.80B	PEG	-	EPS next Q	0.11	Inst Own	88.65%	Short Float	13.15%	Perf Quarter	7.56%
Income	72.55M	P/S	0.70	EPS this Y	-24.23%	Inst Trans	-2.32%	Short Ratio	6.93	Perf Half Y	-18.06%
Sales	1.71B	P/B	0.57	EPS next Y	32.03%	ROA	1.89%	Short Interest	2.65M	Perf YTD	20.95%
Book/sh	90.62	P/C	19.62	EPS next 5Y	-	ROE	3.51%	52W High	80.65 -35.58%	Perf Year	-31.47%
Cash/sh	2.65	P/FCF	-	EPS past 3/5Y	-39.02% -24.55%	ROIC	1.93%	52W Low	39.70 30.88%	Perf 3Y	-50.60%
Dividend Est.	-	EV/EBITDA	33.33	Sales past 3/5Y	-9.55% -6.35%	Gross Margin	20.73%	Volatility	4.72% 5.17%	Perf 5Y	-52.44%
Dividend TTM	-	EV/Sales	1.64	EPS Y/Y TTM	-62.41%	Oper. Margin	4.68%	ATR (14)	2.80	Perf 10Y	121.67%
Dividend Ex-Date	-	Quick Ratio	0.55	Sales Y/Y TTM	-22.57%	Profit Margin	4.25%	RSI (14)	44.82	Recom	2.20
Dividend Gr. 3/5Y	- -	Current Ratio	21.15	EPS Q/Q	-65.30%	SMA20	-6.46%	Beta	1.89	Target Price	65.33
Payout	0.00%	Debt/Eq	0.79	Sales Q/Q	-14.97%	SMA50	2.00%	Rel Volume	0.81	Prev Close	50.89
Employees	1056	LT Debt/Eq	0.79	Earnings	Feb 17 BMO	SMA200	-1.17%	Avg Volume	382.30K	Price	51.96
IPO	Nov 07, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.04% -3.15%	Trades		Volume	309,400	Change	2.10%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-27-25	Upgrade	Seaport Research Partners	Sell → Neutral
Sep-09-24	Upgrade	Wedbush	Underperform → Neutral	$97 → $125
Aug-05-24	Downgrade	Seaport Research Partners	Neutral → Sell	$85
Apr-02-24	Downgrade	Wedbush	Neutral → Underperform	$88 → $74
Oct-02-23	Upgrade	BTIG Research	Sell → Neutral
Jun-14-23	Initiated	Seaport Research Partners	Buy	$156
Feb-22-23	Downgrade	BTIG Research	Neutral → Sell	$73
Apr-20-22	Upgrade	BTIG Research	Sell → Neutral
Mar-23-22	Downgrade	BTIG Research	Neutral → Sell	$98
Dec-09-21	Upgrade	Wells Fargo	Underweight → Equal Weight	$125 → $160
Apr-16-21	Initiated	Wells Fargo	Underweight	$150
Feb-22-21	Initiated	KeyBanc Capital Markets	Sector Weight
Dec-09-20	Initiated	UBS	Buy	$140
Nov-17-20	Downgrade	JP Morgan	Neutral → Underweight	$129
Aug-05-20	Downgrade	Wells Fargo	Overweight → Equal Weight	$122
Jul-21-20	Upgrade	BTIG Research	Sell → Neutral
Jul-14-20	Resumed	JMP Securities	Mkt Outperform	$120
Jun-04-20	Downgrade	Wedbush	Outperform → Neutral
Apr-06-20	Upgrade	Wedbush	Neutral → Outperform	$55
Mar-18-20	Downgrade	JP Morgan	Neutral → Underweight	$39

Show Previous Ratings

Feb-24-26 12:36AM	The Top 5 Analyst Questions From LGI Homes's Q4 Earnings Call (StockStory)
Feb-18-26 12:33AM	LGIH Q4 Deep Dive: Incentives and Backlog Growth Define Performance Amidst Affordability Challenges (StockStory) -6.06%
Feb-17-26 08:05PM	LGI Homes Inc (LGIH) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Margin Pressures (GuruFocus.com)
04:32PM	LGI Homes, Inc. Q4 2025 Earnings Call Summary (Moby)
02:01PM	Why LGI Homes (LGIH) Stock Is Down Today (StockStory)
01:46PM	Loading…
01:46PM	LGI Homes Q4 Earnings Call Highlights (MarketBeat)
08:21AM	LGI Homes: Q4 Earnings Snapshot (Associated Press Finance)
08:09AM	LGI Homes (NASDAQ:LGIH) Misses Q4 CY2025 Revenue Estimates (StockStory)
08:00AM	LGI Homes, Inc. Reports Fourth Quarter and Full Year 2025 Results and Issues Guidance for 2026 (GlobeNewswire)
Feb-15-26 10:04PM	LGI Homes (LGIH) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Feb-11-26 05:00PM	Terrata Homes Celebrates Grand Opening of Murieta Hills, Marking Brand's First Community in California (GlobeNewswire)
Feb-07-26 07:41AM	Citizens Sees Improving Visibility for LGI Homes, Inc. (LGIH) Ahead of Q4 Results (Insider Monkey)
Feb-04-26 06:35PM	LGI Homes, Inc. Reports January 2026 Home Closings (GlobeNewswire) +8.52%
Jan-31-26 08:20AM	LGI Homes announces new community in Modesto, California market (TipRanks)
Jan-30-26 08:00AM	LGI Homes Announces New Community in the Modesto, California Market (GlobeNewswire)
04:30AM	Loading…
Jan-27-26 04:30AM	Bear of the Day: LGI Homes (LGIH) (Zacks)
02:35AM	Amphenol and LGI Homes have been highlighted as Zacks Bull and Bear of the Day (Zacks)
Jan-26-26 08:00AM	LGI Homes Celebrates Opening of New Community Park at Vista West in Fort Worth (GlobeNewswire)
Jan-23-26 05:00PM	Southaven Expands Community Amenities with Opening of New Park (GlobeNewswire)
Jan-20-26 11:31PM	2 Value Stocks Worth Investigating and 1 That Underwhelm (StockStory)
10:23AM	LGI Homes, Inc. (LGIH): A Bear Case Theory (Insider Monkey)
Jan-08-26 10:35PM	Home Builders Stocks Q3 Recap: Benchmarking LGI Homes (NASDAQ:LGIH) (StockStory) +8.39% +13.92%
Jan-07-26 03:15PM	Why LGI Homes (LGIH) Stock Is Up Today (StockStory)
Jan-06-26 06:52PM	LGI Homes Reports 2025 Annual Home Closings and Sets Date for Fourth Quarter and Year End 2025 Earnings Conference Call (GlobeNewswire)
Dec-17-25 03:41PM	Why LGI Homes (LGIH) Stock Is Down Today (StockStory)
Dec-09-25 04:01PM	Why LGI Homes (LGIH) Shares Are Trading Lower Today (StockStory)
Dec-03-25 06:04PM	LGI Homes, Inc. Reports November 2025 Home Closings (GlobeNewswire) -6.54%
Dec-01-25 05:35PM	Congress Beat the Market Again-Here Are the 3 Stocks They Bought (MarketBeat)
05:00PM	LGI Homes Announces Year-End Savings National Sales Event, Extending Exclusive Offers Across LGI Homes and Terrata Homes Communities Nationwide (GlobeNewswire)
Nov-27-25 10:26AM	Can Opendoor's Expanding D2C Funnel Drive a Capital-Light Strategy? (Zacks)
11:02PM	Loading…
Nov-20-25 11:02PM	3 Reasons LGIH is Risky and 1 Stock to Buy Instead (StockStory) +11.17%
08:00AM	Fulton Meadows: New Community Opening in North Lakeland, Florida (GlobeNewswire)
Nov-19-25 04:05PM	Why LGI Homes (LGIH) Shares Are Falling Today (StockStory)
Nov-18-25 11:18AM	Can Opendoor 2.0 Redefine iBuying Through AI and Automation? (Zacks)
Nov-17-25 05:00PM	LGI Homes Announces New Community in the Bakersfield Market (GlobeNewswire) -5.99%
Nov-11-25 12:35AM	LGI Homes's Q3 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Nov-05-25 06:52PM	LGI Homes, Inc. Reports October 2025 Home Closings (GlobeNewswire) +9.40% -5.06%
12:31AM	LGIH Q3 Deep Dive: Orders and Backlog Climb as Incentives Offset Challenged Market (StockStory)
Nov-04-25 08:14PM	LGI Homes Inc (LGIH) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth (GuruFocus.com) +9.13%
08:15AM	LGI Homes (LGIH) Q3 Earnings Miss Estimates (Zacks)
07:16AM	LGI Homes: Q3 Earnings Snapshot (Associated Press Finance)
07:12AM	LGI Homes's (NASDAQ:LGIH) Q3 Sales Beat Estimates (StockStory)
07:00AM	LGI Homes, Inc. Reports Third Quarter 2025 Results (GlobeNewswire)
Nov-02-25 10:16PM	LGI Homes (LGIH) Q3 Earnings Report Preview: What To Look For (StockStory)
Oct-28-25 10:00AM	Earnings Preview: LGI Homes (LGIH) Q3 Earnings Expected to Decline (Zacks)
07:40AM	D.R. Horton (DHI) Q4 Earnings Miss Estimates (Zacks)
Oct-27-25 05:00PM	LGI Homes Extends "Make Your Move" National Sales Event Through November 2 (GlobeNewswire)
Oct-21-25 08:13PM	LGI Homes, Inc. (LGIH): A Bear Case Theory (Insider Monkey)
Oct-14-25 05:00PM	LGI Homes Debuts Four New Floor Plans at Oquirrh Mountain Ranch in Eagle Mountain, Utah (GlobeNewswire) +7.22%
Oct-13-25 08:00AM	LGI Homes Announces Rivenwick Village: A New Community Offering Townhome Living in Ramsey, MN (GlobeNewswire)
Oct-10-25 08:00AM	Terrata Homes Announces Limited-Release Community: Stables at Cary Forest (GlobeNewswire)
Oct-09-25 10:10AM	Lagging Builder Stocks Face New Worry From Bill Pultes Ire (Bloomberg)
08:00AM	Terrata Homes Expands Nashville Market Presence with Hickory Knoll (GlobeNewswire)
12:04AM	3 Reasons to Avoid LGIH and 1 Stock to Buy Instead (StockStory)
Oct-08-25 05:00PM	Terrata Homes Unveils Gardens at Skyway: Modern Townhome Living in Seattle (GlobeNewswire)
Oct-07-25 03:35PM	LGI Homes, LSI, WESCO, DistributionNOW, and MRC Global Stocks Trade Down, What You Need To Know (StockStory) -7.08%
Oct-03-25 05:21PM	LGI Homes Reports September and Third Quarter 2025 Home Closings and Announces Date for Third Quarter Earnings Conference Call (GlobeNewswire) -5.74%
Sep-25-25 05:00PM	LGI Homes Unveils Exciting New Floor Plans at Lago Mar in Texas City (GlobeNewswire) -5.27%
Sep-22-25 08:00AM	LGI Homes Returns to Rio Rancho, NM, with the Grand Opening of Estrella at High Range (GlobeNewswire)
Sep-19-25 05:00PM	LGI Homes Opens New Community near Olympia, WA (GlobeNewswire)
Sep-16-25 05:00PM	LGI Homes Kicks Off Annual "Make Your Move" National Sales Event (GlobeNewswire)
02:50PM	Citizens JMP Lifts PT on LGI Homes (LGIH) Stock (Insider Monkey)
Sep-09-25 11:31AM	LGI Homes (LGIH) Stock Trades Down, Here Is Why (StockStory) -5.45%
Sep-04-25 05:33PM	LGI Homes, Inc. Reports August 2025 Home Closings (GlobeNewswire)
Sep-02-25 11:32PM	Home Builders Stocks Q2 Recap: Benchmarking LGI Homes (NASDAQ:LGIH) (StockStory)
06:59AM	U.S. homebuilding stocks in focus as Trump team weighs housing emergency (Investing.com)
Aug-27-25 05:33PM	LGI Homes Opens New Master-Planned Community in Jarrell, Texas (GlobeNewswire)
Aug-22-25 03:30PM	Why Is LGI Homes (LGIH) Stock Rocketing Higher Today (StockStory) +8.79%
11:53AM	Jackson Hole Gives Home Buyers-and Builders-a Boost (Barrons.com)
Aug-21-25 05:30PM	LGI Homes Announces Homes for Sale at Neuse Ridge in Clayton, NC (GlobeNewswire)
02:55PM	LGI Homes, Moderna, Fortrea, 10x Genomics, and Cogent Shares Are Falling, What You Need To Know (StockStory)
Aug-20-25 05:00PM	LGI Homes Expands Presence Near Fort Pierce in Indian River Estates (GlobeNewswire)
12:36AM	3 Cash-Burning Stocks Walking a Fine Line (StockStory)
Aug-14-25 06:00PM	LGI Homes Introduces 17 New Floor Plans Across Minneapolis Area Communities (GlobeNewswire)
Aug-13-25 12:13AM	The Top 5 Analyst Questions From LGI Homes's Q2 Earnings Call (StockStory) +8.77%
12:12AM	LGIH Q2 Deep Dive: Incentives and Affordability Strategies in a Softer Market (StockStory)
Aug-12-25 12:16PM	Why LGI Homes (LGIH) Stock Is Up Today (StockStory) +7.90%
Aug-07-25 05:00PM	UPDATE -- LGI Homes Opens Brayden Preserve: New Community in Mamers, North Carolina (GlobeNewswire)
08:00AM	LGI Homes Opens Brayden Preserve: New Community in Mamers, North Carolina (GlobeNewswire)
Aug-06-25 03:25AM	LGI Homes Inc (LGIH) Q2 2025 Earnings Call Highlights: Navigating Market Challenges with ... (GuruFocus.com)
Aug-05-25 06:08PM	LGI Homes, Inc. Reports July 2025 Home Closings (GlobeNewswire) +8.60%
08:20AM	LGI Homes (LGIH) Q2 Earnings and Revenues Surpass Estimates (Zacks)
07:57AM	LGI Homes (NASDAQ:LGIH) Reports Q2 In Line With Expectations (StockStory)
07:25AM	LGI Homes: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	LGI Homes, Inc. Reports Second Quarter 2025 Results (GlobeNewswire)
Aug-03-25 11:04PM	LGI Homes (LGIH) Reports Earnings Tomorrow: What To Expect (StockStory)
Jul-30-25 04:00PM	LGI Homes Debuts Rhyne Court in Gastonia, NC (GlobeNewswire)
Jul-29-25 10:00AM	Earnings Preview: LGI Homes (LGIH) Q2 Earnings Expected to Decline (Zacks)
Jul-28-25 09:50AM	Bank of Marin (BMRC) Q2 Earnings Miss Estimates (Zacks)
12:03AM	3 Reasons LGIH is Risky and 1 Stock to Buy Instead (StockStory)
Jul-25-25 08:00AM	LGI Homes Debuts Robindale Community East of Downtown Winston-Salem (GlobeNewswire)
Jul-23-25 05:22PM	LGI Homes Unveils New Townhome Plans at Cottonwood Greens in Fort Lupton, Colorado (GlobeNewswire)
Jul-21-25 04:38PM	LGI Homes Unveils New Phase at Atherstone, Bringing More Affordable Homes to Angier, North Carolina (GlobeNewswire) +15.80%
Jul-15-25 04:30PM	LGI Homes Debuts Three New Floor Plans at The Valley in Elgin, South Carolina (GlobeNewswire) -6.62%
Jul-11-25 04:30PM	Crystal Creek by LGI Homes Brings Premium Townhome Living to Spring Hill, TN (GlobeNewswire)
08:36AM	Implied Volatility Surging for LGI Homes Stock Options (Zacks)
Jul-03-25 05:49PM	LGI Homes, Inc. Reports June and Second Quarter 2025 Home Closings and Announces Date for Second Quarter Earnings Conference Call (GlobeNewswire)
Jul-01-25 05:25PM	LGI Homes Unveils $3M Amenity Center at Jennings Farm in Middleburg, FL (GlobeNewswire) +6.41%
Jun-30-25 12:33AM	3 Russell 2000 Stocks in Hot Water (StockStory)
Jun-27-25 04:56PM	LGI Homes Introduces Medley Park in Clayton, NC: A Stylish Townhome Community Close to Raleigh (GlobeNewswire)

LGI Homes, Inc. engages in the design, construction, marketing, and sale of new homes. It focuses on the residential land development business. It operates through the following segments: Central, West, Southeast, Florida, Midwest, Mid-Atlantic, and Northwest. The company was founded by Eric Thomas Lipar in 2003 and is headquartered in The Woodlands, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lipar Eric Thomas	CEO and Chairman of the Board	Mar 11 '25	Sale	75.94	3,489	264,955	634,978	Mar 11 06:41 PM
Snider Michael Larry	President and COO	Mar 10 '25	Sale	75.94	1,105	83,914	27,102	Mar 11 06:41 PM
Snider Michael Larry	Officer	Mar 10 '25	Proposed Sale	76.02	1,105	84,000		Mar 10 12:54 PM
Lipar Eric Thomas	Officer	Mar 10 '25	Proposed Sale	75.67	3,489	264,000		Mar 10 12:31 PM

Open in Screener

VRTX

Vertex Pharmaceuticals, Inc

Feb 26 • 04:00PM ET

480.13

-2.92 -0.60 %

Healthcare • Biotechnology • USA • NASD

VRTX Vertex Pharmaceuticals, Inc daily Stock Chart

Peers: BIIB GILD AMGN REGN MRNA INCY ALNY NBIX EXEL

| Held by: VTI VOO QQQ IVV SPY VUG XLV IBB IWF QQQM

Index	NDX, S&P 500	P/E	31.31	EPS (ttm)	15.33	Insider Own	0.33%	Shs Outstand	253.99M	Perf Week	2.31%
Market Cap	121.97B	Forward P/E	21.60	EPS next Y	22.23	Insider Trans	-24.03%	Shs Float	253.20M	Perf Month	1.26%
Enterprise Value	117.39B	PEG	2.26	EPS next Q	4.42	Inst Own	94.15%	Short Float	1.75%	Perf Quarter	13.24%
Income	3.95B	P/S	10.10	EPS this Y	5.22%	Inst Trans	-0.70%	Short Ratio	3.09	Perf Half Y	24.01%
Sales	12.07B	P/B	6.53	EPS next Y	14.81%	ROA	16.06%	Short Interest	4.42M	Perf YTD	5.90%
Book/sh	73.49	P/C	18.45	EPS next 5Y	9.56%	ROE	22.54%	52W High	519.68 -7.61%	Perf Year	0.21%
Cash/sh	26.02	P/FCF	38.19	EPS past 3/5Y	6.12% 8.28%	ROIC	19.17%	52W Low	362.50 32.45%	Perf 3Y	67.08%
Dividend Est.	-	EV/EBITDA	23.63	Sales past 3/5Y	11.34% 14.23%	Gross Margin	86.32%	Volatility	2.46% 2.84%	Perf 5Y	125.89%
Dividend TTM	-	EV/Sales	9.72	EPS Y/Y TTM	848.30%	Oper. Margin	39.43%	ATR (14)	13.21	Perf 10Y	451.87%
Dividend Ex-Date	-	Quick Ratio	2.46	Sales Y/Y TTM	9.92%	Profit Margin	32.74%	RSI (14)	54.81	Recom	1.66
Dividend Gr. 3/5Y	- -	Current Ratio	2.90	EPS Q/Q	32.70%	SMA20	1.42%	Beta	0.32	Target Price	537.75
Payout	0.00%	Debt/Eq	0.11	Sales Q/Q	11.76%	SMA50	3.28%	Rel Volume	0.91	Prev Close	483.05
Employees	6400	LT Debt/Eq	0.10	Earnings	Feb 12 AMC	SMA200	10.14%	Avg Volume	1.43M	Price	480.13
IPO	Jul 24, 1991	Option/Short	Yes / Yes	EPS/Sales Surpr.	-1.58% 0.18%	Trades		Volume	1,305,132	Change	-0.60%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-13-26	Upgrade	Oppenheimer	Perform → Outperform	$540
Jan-28-26	Resumed	Barclays	Overweight	$606
Jan-22-26	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$546
Jan-12-26	Upgrade	Bernstein	Mkt Perform → Outperform
Jan-07-26	Resumed	UBS	Buy	$535
Jan-06-26	Upgrade	Wolfe Research	Peer Perform → Outperform	$548
Dec-03-25	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$516
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$495
Sep-25-25	Upgrade	Leerink Partners	Market Perform → Outperform	$456
Sep-03-25	Initiated	Raymond James	Mkt Perform
Aug-06-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$460
May-07-25	Downgrade	Wolfe Research	Outperform → Peer Perform
May-06-25	Downgrade	Leerink Partners	Outperform → Market Perform	$503
Apr-22-25	Resumed	Cantor Fitzgerald	Overweight	$535
Feb-12-25	Upgrade	Canaccord Genuity	Sell → Hold	$408 → $424
Feb-11-25	Upgrade	Canaccord Genuity	Sell → Hold
Jan-30-25	Downgrade	Wells Fargo	Overweight → Equal Weight	$460
Dec-20-24	Reiterated	H.C. Wainwright	Buy	$600 → $535
Dec-19-24	Downgrade	Oppenheimer	Outperform → Perform
Dec-09-24	Upgrade	Jefferies	Hold → Buy	$500 → $550

Show Previous Ratings

Today 03:40PM	Physician-Scientist Reshma Kewalramani Runs One of Biotechs Biggest Companies (Time)
07:35AM	Is Vertex Stock Outperforming the Dow? (Barchart)
Feb-25-26 11:33AM	Novo Nordisk's 40% Fall May Be Creating A Deep-Value Moment (Benzinga)
Feb-24-26 06:44PM	Analyst Report: CRISPR Therapeutics AG (Morningstar Research)
Feb-19-26 12:32PM	CRISPR Therapeutics Gains After Earnings as Pipeline Hope Grows (MarketBeat)
07:16AM	Loading…
07:16AM	CRISPR Therapeutics touts zugo-cel CAR-T gains, eyes autoimmune expansion at Citi oncology summit (MarketBeat)
12:37AM	5 Insightful Analyst Questions From Vertex Pharmaceuticals's Q4 Earnings Call (StockStory)
Feb-17-26 05:10PM	Analyst Report: Vertex Pharmaceuticals Incorporated (Morningstar Research)
04:17PM	Analyst Report: CRISPR Therapeutics AG (Morningstar Research)
04:00PM	Vertex to Participate in TD Cowen 46th Annual Health Care Conference on March 3 (Business Wire)
09:00AM	Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock (Zacks)
12:21AM	Vertex Pharmaceuticals Stock: Is Wall Street Bullish or Bearish? (Barchart)
Feb-16-26 07:48AM	Moderna's Shares Climb 5.3% as Investors Revisit Biotech Leaders (Zacks)
Feb-15-26 03:02PM	Entrada Therapeutics Teases Data-Rich 2026 With DMD and DM1 Catalysts at Guggenheim Summit (MarketBeat)
Feb-14-26 09:06AM	Crispr Therapeutics price target raised to $74 from $62 at Evercore ISI (TipRanks)
01:48PM	Loading…
Feb-13-26 01:48PM	Small Caps, Silver Rally As Inflation Cools Further: What's Moving Markets Friday? (Benzinga) +5.69%
01:45PM	CRISPR Therapeutics Spotlights Momentum For Lead Gene Therapy As Adoption Widens (Benzinga)
11:53AM	VRTX's Q4 Earnings Miss Mark, Revenues Beat on Higher Product Sales (Zacks)
11:38AM	Moderna Q4 Loss Narrower-Than-Expected, Sales Beat Estimates (Zacks)
10:04AM	CRSP Posts Wider-Than-Expected Loss in Q4, Sales Miss Estimates (Zacks)
09:54AM	Vertex Pharma (VRTX) Renal Pipeline Seen as Major Growth Driver by Barclays (Insider Monkey)
09:49AM	Stock Market Today: Dow Slips After CPI Inflation Surprise; DraftKings Plunges On Earnings (Live Coverage) (Investor's Business Daily)
12:32AM	VRTX Q4 Deep Dive: Diversification Beyond Cystic Fibrosis Sets Stage for Next Growth Phase (StockStory)
12:05AM	Vertex Pharmaceuticals Inc (VRTX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Feb-12-26 11:14PM	Vertex Pharmaceuticals (VRTX) Stock Drops After Hours - Here's Why It's Trending Tonight (Benzinga)
09:07PM	Vertex Pharmaceuticals Q4 Earnings Call Highlights (MarketBeat)
06:00PM	Vertex (VRTX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:20PM	Vertex Pharmaceuticals (VRTX) Q4 Earnings Miss Estimates (Zacks)
04:17PM	Vertex: Q4 Earnings Snapshot (Associated Press Finance)
04:11PM	Vertex Pharmaceuticals's (NASDAQ:VRTX) Q4 CY2025: Beats On Revenue (StockStory)
04:01PM	Loading…
04:01PM	Vertex Reports Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
09:50AM	Why Vertex Pharmaceuticals (VRTX) is a Top Momentum Stock for the Long-Term (Zacks)
Feb-10-26 10:03PM	Vertex Pharmaceuticals (VRTX) Q4 Earnings: What To Expect (StockStory)
11:10AM	LLY Expands Cell Therapy Ambitions With $2.4B Orna Therapeutics Deal (Zacks)
10:45AM	Vertex Gears Up to Report Q4 Earnings: Is a Beat in the Cards? (Zacks)
Feb-09-26 11:38AM	Will These 5 Drug Bigwigs Surpass Q4 Earnings Forecasts? (Zacks)
11:30AM	Robinhood, AppLovin, Rivian and More Stocks With Earnings This Week (Benzinga)
09:15AM	Seeking Clues to Vertex (VRTX) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
08:55AM	How to Find Strong Medical Stocks Slated for Positive Earnings Surprises (Zacks)
Feb-05-26 07:28PM	Analyst Report: CRISPR Therapeutics AG (Morningstar Research)
10:00AM	Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Feb-04-26 10:28AM	Software stocks take hit on AI. Is Wall Street worried of a bubble? (Yahoo Finance Video)
08:55AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Feb-03-26 02:57PM	These Are The Worst 25 Stocks to Own in February (Schaeffer's Research)
09:00AM	Is Trending Stock Vertex Pharmaceuticals Incorporated (VRTX) a Buy Now? (Zacks)
08:30AM	Here's How Much a $1000 Investment in Vertex Pharmaceuticals Made 10 Years Ago Would Be Worth Today (Zacks)
08:30AM	CRSP to Report Q4 Earnings: Is a Beat in Store for the Stock? (Zacks)
Jan-31-26 11:31AM	Why Analysts Are Positive on Vertex Pharmaceuticals Incorporated (VRTX)'s Story (Insider Monkey)
Jan-30-26 05:50PM	Why Vertex Pharmaceuticals (VRTX) Dipped More Than Broader Market Today (Zacks)
11:15AM	Dow Jones Leader Amgen Leads These Biotech Stocks Heading Into Q4 Earnings Season (Investor's Business Daily)
Jan-29-26 05:19PM	Top Analyst Reports for Applied Materials, Linde & Abbott (Zacks)
09:20AM	Prediction: 2026 Will Be the Year of Vertex Pharmaceuticals (Motley Fool)
07:00AM	Satellos Appoints Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs (Business Wire)
Jan-28-26 11:34PM	1 Healthcare Stock to Consider Right Now and 2 We Brush Off (StockStory)
07:31AM	Here's Why Hardman Johnston Global Equity Strategy Sold Vertex Pharmaceuticals (VRTX) (Insider Monkey)
Jan-26-26 10:16AM	Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets (PR Newswire)
Jan-23-26 09:30AM	Wall Street Analysts Think Vertex (VRTX) Is a Good Investment: Is It? (Zacks)
Jan-22-26 06:00PM	Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider (Zacks)
12:07AM	Why Is Vertex Pharmaceuticals (VRTX) Stock Trending Overnight? (Benzinga)
Jan-21-26 10:35PM	Reflecting On Therapeutics Stocks' Q3 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) (StockStory)
Jan-20-26 04:00PM	Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th (Business Wire)
Jan-19-26 10:31PM	Unpacking Q3 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks (StockStory)
07:49AM	Bernstein Names Vertex (VRTX) a "Top Biotech Pick" for 2026 Following Upgrade to Outperform (Insider Monkey)
05:04AM	My Forever Portfolio: 5 Stocks I Don't Plan on Ever Selling (Motley Fool)
Jan-16-26 08:54AM	Implied Volatility Surging for Vertex Pharmaceuticals Stock Options (Zacks)
Jan-15-26 06:00PM	Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why (Zacks)
08:55AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
Jan-14-26 11:35AM	Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030 (Motley Fool)
Jan-13-26 10:25AM	JPM26: Vertex hopes to match cystic fibrosis success in pain and kidney disease (Pharmaceutical Technology)
09:31AM	Here's What to Expect From Vertex Pharmaceuticals' Next Earnings Report (Barchart)
Jan-12-26 12:10PM	Will Vertex (VRTX) Beat Estimates Again in Its Next Earnings Report? (Zacks)
09:05AM	Here's What Lifted Vertex Pharmaceuticals (VRTX) in Q4 (Insider Monkey)
06:24AM	AbbVie buys into PD-1/VEGF sweepstakes; Alnylam and Vertex set expectations (BioPharma Dive)
Jan-11-26 05:00PM	Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings (Business Wire)
06:01AM	The Best Stocks to Invest $50,000 in Right Now (Motley Fool)
Jan-09-26 05:50PM	Vertex Pharmaceuticals (VRTX) Stock Dips While Market Gains: Key Facts (Zacks)
09:50AM	Prediction: 2 Healthcare Stocks That Will Be Worth More Than Pfizer by the End of 2026 (Motley Fool)
Jan-08-26 06:00PM	Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Jan-07-26 09:00AM	Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
06:00AM	Bank of America Says These 2 Healthcare Stocks Are Top Ideas for 1Q26 (TipRanks)
Jan-06-26 05:00PM	Top Research Reports for JPMorgan Chase, RTX & Applied Materials (Zacks)
03:06PM	Vertex Pharmaceuticals (VRTX) Stock Trades Up, Here Is Why (StockStory)
Jan-05-26 08:35PM	My 10 Top Stocks to Buy to Start the New Year Off Right (Motley Fool)
Jan-02-26 01:29PM	Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize (PR Newswire)
11:12AM	BofA unveils its top 10 U.S. ideas for Q1 2026 (Investing.com)
Jan-01-26 06:05AM	The Best Stocks to Invest $1,000 in to Start the New Year Off Right (Motley Fool)
Dec-30-25 05:50PM	Vertex Pharmaceuticals (VRTX) Dips More Than Broader Market: What You Should Know (Zacks)
04:31PM	Stocks Fall Slightly in Thin Holiday Trade (Barchart)
11:06AM	Stocks Slip as Bond Yields Rise (Barchart)
09:50AM	Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Momentum Stock (Zacks)
08:20AM	2 Growth Stocks to Buy For 2026 and Beyond (Motley Fool)
08:10AM	Vertex Pharmaceuticals price target raised to $525 from $456 at Leerink (TipRanks)
Dec-29-25 08:42AM	Should You Be Confident in Vertex Pharmaceuticals Incorporated's (VRTX) Long-Term Outlook? (Insider Monkey)
Dec-28-25 01:33PM	3 Supercharged Growth Stocks to Buy and Hold Into the 2030s (Motley Fool)
Dec-27-25 10:30AM	Forget Moderna Stock, This is a Much Better Buy (Motley Fool)
Dec-24-25 04:35AM	Is CRISPR Therapeutics Stock Yesterday's News? (Motley Fool)
Dec-23-25 09:00AM	Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Dec-22-25 04:00PM	Vertex to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12 (Business Wire)
Dec-19-25 07:05AM	Is CRISPR Therapeutics a Buy, Sell, or Hold in 2026? (Motley Fool)
Dec-17-25 11:02PM	2 Reasons to Watch VRTX and 1 to Stay Cautious (StockStory)

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Feb 25 '26	Sale	486.35	260	126,451	46,763	Feb 26 06:55 PM
Sachdev Amit	EVP Chief Patient & Ext Af Off	Feb 25 '26	Sale	486.35	1,846	897,802	55,570	Feb 26 06:50 PM
McKechnie Duncan	EVP, Chief Commercial Officer	Feb 25 '26	Sale	487.65	4,910	2,394,365	17,559	Feb 26 06:48 PM
Bunnage Mark E.	EVP, Chief Scientific Officer	Feb 25 '26	Sale	486.35	620	301,537	7,284	Feb 26 06:06 PM
Biller Jonathan	EVP and Chief Legal Officer	Feb 25 '26	Sale	486.35	945	459,601	13,659	Feb 26 06:01 PM
Atkinson Edward Morrow III	EVP, Chief Technical Ops. Off.	Feb 25 '26	Sale	486.35	668	324,882	18,432	Feb 26 06:00 PM
Ambrose Kristen	SVP & Chief Accounting Officer	Feb 25 '26	Sale	486.35	223	108,456	6,981	Feb 26 05:56 PM
McKechnie Duncan	Officer	Feb 25 '26	Proposed Sale	487.65	4,910	2,394,365		Feb 25 11:28 AM
Tatsis Ourania	Officer	Feb 25 '26	Proposed Sale	486.35	260	126,451		Feb 25 11:12 AM
Bunnage Mark E.	Officer	Feb 25 '26	Proposed Sale	486.35	620	301,537		Feb 25 11:02 AM
Atkinson Edward Morrow III	Officer	Feb 25 '26	Proposed Sale	486.35	668	324,882		Feb 25 10:35 AM
Sachdev Amit	Officer	Feb 25 '26	Proposed Sale	486.35	1,846	897,802		Feb 25 10:06 AM
Biller Jonathan	Officer	Feb 25 '26	Proposed Sale	486.35	945	459,601		Feb 25 09:41 AM
Sachdev Amit	EVP Chief Patient & Ext Af Off	Feb 19 '26	Option Exercise	172.06	48,505	8,345,754	117,547	Feb 23 04:21 PM
Sachdev Amit	EVP Chief Patient & Ext Af Off	Feb 19 '26	Sale	468.83	58,613	27,479,583	58,934	Feb 23 04:21 PM
Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Feb 17 '26	Sale	489.46	609	298,081	49,018	Feb 19 04:28 PM
Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Feb 18 '26	Sale	473.68	368	174,314	48,650	Feb 19 04:28 PM
Sachdev Amit	Officer	Feb 19 '26	Proposed Sale	468.83	58,613	27,479,576		Feb 19 04:18 PM
Bunnage Mark E.	EVP, Chief Scientific Officer	Feb 17 '26	Sale	489.46	2,437	1,192,814	9,668	Feb 19 04:12 PM
Bunnage Mark E.	EVP, Chief Scientific Officer	Feb 18 '26	Sale	473.68	1,182	559,890	8,486	Feb 19 04:12 PM
Biller Jonathan	EVP and Chief Legal Officer	Feb 17 '26	Sale	489.46	2,476	1,211,903	16,992	Feb 19 04:08 PM
Biller Jonathan	EVP and Chief Legal Officer	Feb 18 '26	Sale	473.68	1,244	589,258	15,748	Feb 19 04:08 PM
Atkinson Edward Morrow III	EVP, Chief Technical Ops. Off.	Feb 17 '26	Sale	489.46	2,031	994,093	21,544	Feb 19 04:06 PM
Atkinson Edward Morrow III	EVP, Chief Technical Ops. Off.	Feb 18 '26	Sale	473.68	817	386,997	20,727	Feb 19 04:06 PM
Ambrose Kristen	SVP & Chief Accounting Officer	Feb 17 '26	Sale	489.46	1,557	762,089	8,388	Feb 19 04:03 PM
Ambrose Kristen	SVP & Chief Accounting Officer	Feb 18 '26	Sale	473.68	638	302,208	7,750	Feb 19 04:03 PM
Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Feb 13 '26	Sale	499.99	1,500	749,985	46,132	Feb 18 04:43 PM
Biller Jonathan	EVP and Chief Legal Officer	Feb 13 '26	Sale	499.00	988	493,012	16,838	Feb 18 04:26 PM
Bhatia Sangeeta N.	Director	Feb 13 '26	Sale	500.00	266	133,000	4,299	Feb 18 04:23 PM
Tatsis Ourania	Officer	Feb 18 '26	Proposed Sale	473.68	368	174,314		Feb 18 12:28 PM
Biller Jonathan	Officer	Feb 18 '26	Proposed Sale	473.68	1,244	589,258		Feb 18 10:46 AM
Bunnage Mark E.	Officer	Feb 18 '26	Proposed Sale	473.68	1,182	559,890		Feb 18 10:17 AM
Atkinson Edward Morrow III	Officer	Feb 18 '26	Proposed Sale	473.68	817	386,997		Feb 18 09:55 AM
Bunnage Mark E.	Officer	Feb 17 '26	Proposed Sale	489.46	2,437	1,192,814		Feb 17 03:26 PM
Tatsis Ourania	Officer	Feb 17 '26	Proposed Sale	489.46	609	298,081		Feb 17 02:34 PM
Biller Jonathan	Officer	Feb 17 '26	Proposed Sale	489.46	2,476	1,211,903		Feb 17 01:52 PM
Atkinson Edward Morrow III	Officer	Feb 17 '26	Proposed Sale	489.46	2,031	994,093		Feb 17 01:20 PM
Biller Jonathan	Officer	Feb 13 '26	Proposed Sale	499.00	988	493,012		Feb 13 02:59 PM
Bhatia Sangeeta N.	Director	Feb 13 '26	Proposed Sale	500.00	266	133,000		Feb 13 02:54 PM
Tatsis Ourania	Officer	Feb 13 '26	Proposed Sale	499.99	1,500	749,992		Feb 13 02:43 PM
Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Feb 11 '26	Sale	460.43	466	214,560	51,436	Feb 12 05:08 PM
Bunnage Mark E.	EVP, Chief Scientific Officer	Feb 11 '26	Sale	460.43	2,021	930,529	12,914	Feb 12 04:56 PM
Biller Jonathan	EVP and Chief Legal Officer	Feb 11 '26	Sale	460.43	1,925	886,328	20,819	Feb 12 04:52 PM
Atkinson Edward Morrow III	EVP, Chief Technical Ops. Off.	Feb 11 '26	Sale	460.43	1,751	806,213	22,046	Feb 12 04:50 PM
Ambrose Kristen	SVP & Chief Accounting Officer	Feb 11 '26	Sale	460.43	1,376	633,552	10,127	Feb 12 04:47 PM
Biller Jonathan	Officer	Feb 11 '26	Proposed Sale	460.43	1,925	886,328		Feb 11 11:30 AM
Atkinson Edward Morrow III	Officer	Feb 11 '26	Proposed Sale	460.43	1,751	806,213		Feb 11 10:58 AM
Bunnage Mark E.	Officer	Feb 11 '26	Proposed Sale	460.43	2,021	930,529		Feb 11 10:18 AM
Tatsis Ourania	Officer	Feb 11 '26	Proposed Sale	460.43	466	214,560		Feb 11 09:47 AM
Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Jan 07 '26	Sale	474.99	4,500	2,137,455	42,293	Jan 09 04:05 PM
WAGNER CHARLES F JR	EVP, CO & FO	Jan 06 '26	Option Exercise	189.38	9,532	1,805,170	47,257	Jan 08 04:04 PM
WAGNER CHARLES F JR	EVP, CO & FO	Jan 06 '26	Sale	461.00	9,532	4,394,252	37,725	Jan 08 04:04 PM
Tatsis Ourania	Officer	Jan 07 '26	Proposed Sale	474.99	4,500	2,137,455		Jan 07 10:31 AM
WAGNER CHARLES F JR	Officer	Jan 06 '26	Proposed Sale	461.00	9,532	4,394,252		Jan 06 11:16 AM
WAGNER CHARLES F JR	EVP, CO & FO	Dec 03 '25	Sale	456.00	14,000	6,384,000	37,725	Dec 05 04:16 PM
Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Dec 03 '25	Sale	449.99	4,500	2,024,955	46,793	Dec 05 04:12 PM
LEIDEN JEFFREY M	Executive Chairman	Dec 03 '25	Option Exercise	86.52	63,781	5,518,332	87,807	Dec 05 04:10 PM
LEIDEN JEFFREY M	Executive Chairman	Dec 04 '25	Option Exercise	91.05	1	91	24,027	Dec 05 04:10 PM
LEIDEN JEFFREY M	Executive Chairman	Dec 03 '25	Sale	449.20	63,781	28,650,337	24,026	Dec 05 04:10 PM
Biller Jonathan	EVP and Chief Legal Officer	Dec 03 '25	Sale	449.00	347	155,803	15,306	Dec 05 04:06 PM
JEFFREY M LEIDEN	Director	Dec 03 '25	Proposed Sale	433.15	63,781	27,626,740		Dec 03 04:34 PM
WAGNER CHARLES F JR	Officer	Dec 03 '25	Proposed Sale	461.00	7,000	3,227,000		Dec 03 01:01 PM
WAGNER CHARLES F JR	Officer	Dec 03 '25	Proposed Sale	451.00	7,000	3,157,000		Dec 03 11:24 AM
Tatsis Ourania	Officer	Dec 03 '25	Proposed Sale	449.99	4,500	2,024,955		Dec 03 11:00 AM
Biller Jonathan	Officer	Dec 03 '25	Proposed Sale	449.00	347	155,803		Dec 03 10:52 AM
CARNEY LLOYD	Director	Nov 20 '25	Proposed Sale	426.36	800	341,088		Nov 20 10:27 AM
Atkinson Edward Morrow III	EVP, Chief Technical Ops. Off.	Nov 17 '25	Sale	434.58	2,500	1,086,450	16,852	Nov 19 04:06 PM
LEIDEN JEFFREY M	Executive Chairman	Nov 14 '25	Option Exercise	87.69	53,604	4,700,491	77,630	Nov 17 04:12 PM
LEIDEN JEFFREY M	Executive Chairman	Nov 13 '25	Option Exercise	91.05	19,688	1,792,592	43,714	Nov 17 04:12 PM
LEIDEN JEFFREY M	Executive Chairman	Nov 14 '25	Sale	440.72	53,604	23,624,306	24,026	Nov 17 04:12 PM
LEIDEN JEFFREY M	Executive Chairman	Nov 13 '25	Sale	440.27	19,688	8,668,014	24,026	Nov 17 04:12 PM
Atkinson Edward Morrow III	Officer	Nov 17 '25	Proposed Sale	434.58	2,500	1,086,450		Nov 17 10:50 AM
JEFFREY M LEIDEN	Director	Nov 14 '25	Proposed Sale	434.52	53,604	23,292,010		Nov 14 04:25 PM
JEFFREY M LEIDEN	Director	Nov 13 '25	Proposed Sale	434.19	19,688	8,548,333		Nov 13 04:28 PM
Biller Jonathan	EVP and Chief Legal Officer	Oct 02 '25	Sale	404.21	694	280,522	15,653	Oct 03 04:07 PM
Biller Jonathan	Officer	Oct 02 '25	Proposed Sale	404.21	694	280,522		Oct 02 10:39 AM
Bhatia Sangeeta N.	Director	Aug 27 '25	Sale	386.69	266	102,860	4,565	Aug 29 04:02 PM
Bhatia Sangeeta N.	Director	Aug 27 '25	Proposed Sale	386.69	266	102,860		Aug 27 09:38 AM
Kewalramani Reshma	CEO & President	Aug 06 '25	Buy	389.58	10,000	3,895,768	115,968	Aug 07 04:23 PM
SACHS BRUCE I	Director	Aug 06 '25	Buy	389.68	5,000	1,948,416	45,000	Aug 07 04:19 PM
LR 2019 Benefit Trust	Director	May 21 '25	Proposed Sale	447.18	170	76,021		May 21 04:58 PM
SR 2019 Benefit Trust	Director	May 21 '25	Proposed Sale	447.18	170	76,021		May 21 04:58 PM
ALTSHULER DAVID	EVP, Chief Scientific Officer	May 15 '25	Sale	424.69	52	22,084	23,281	May 19 05:07 PM
ALTSHULER DAVID	Officer	May 15 '25	Proposed Sale	424.69	52	22,084		May 15 10:36 AM
Bhatia Sangeeta N.	Director	May 02 '25	Sale	505.86	400	202,344	4,831	May 05 04:14 PM
Bhatia Sangeeta N.	Director	May 02 '25	Proposed Sale	505.86	400	202,344		May 02 09:47 AM
ALTSHULER DAVID	EVP, Chief Scientific Officer	Mar 13 '25	Sale	510.00	3,231	1,647,810	23,281	Mar 17 04:09 PM
ALTSHULER DAVID	Officer	Mar 13 '25	Proposed Sale	510.00	3,231	1,647,810		Mar 13 11:10 AM
WAGNER CHARLES F JR	EVP & Chief Financial Officer	Mar 10 '25	Sale	500.00	3,298	1,649,000	51,671	Mar 12 04:11 PM
Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Mar 10 '25	Sale	499.99	3,242	1,620,968	51,239	Mar 12 04:10 PM
ALTSHULER DAVID	EVP, Chief Scientific Officer	Mar 10 '25	Sale	500.00	3,231	1,615,500	26,512	Mar 12 04:08 PM
Tatsis Ourania	Officer	Mar 10 '25	Proposed Sale	499.99	3,242	1,620,968		Mar 10 01:58 PM
WAGNER CHARLES F JR	Officer	Mar 10 '25	Proposed Sale	500.00	3,298	1,649,000		Mar 10 01:02 PM
ALTSHULER DAVID	Officer	Mar 10 '25	Proposed Sale	500.00	3,231	1,615,500		Mar 10 12:42 PM
Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Mar 04 '25	Sale	485.49	4,058	1,970,118	54,481	Mar 06 04:08 PM
ALTSHULER DAVID	EVP, Chief Scientific Officer	Mar 03 '25	Sale	490.00	3,231	1,583,190	29,743	Mar 05 04:08 PM
Tatsis Ourania	Officer	Mar 04 '25	Proposed Sale	485.49	4,058	1,970,118		Mar 04 01:39 PM
ALTSHULER DAVID	Officer	Mar 03 '25	Proposed Sale	490.00	3,231	1,583,190		Mar 03 04:17 PM
Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Feb 27 '25	Sale	475.34	530	251,930	58,539	Feb 28 04:48 PM
Atkinson Edward Morrow III	EVP, Chief Technical Ops. Off.	Feb 27 '25	Sale	475.34	2,650	1,259,651	19,352	Feb 28 04:36 PM

BZUN

Baozun Inc ADR

LGIH

LGI Homes Inc

VRTX

Vertex Pharmaceuticals, Inc

Upgrade your FINVIZ experience